Carl A Melbourne
Overview
Explore the profile of Carl A Melbourne including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
412
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee P, Guyatt A, John C, Ali A, Wang X, Williams A, et al.
Wellcome Open Res
. 2024 Dec;
6:349.
PMID: 39669688
New data collection in established longitudinal population studies provides an opportunity for studying the risk factors and sequelae of the novel coronavirus disease 2019 (COVID-19), plus the indirect impacts of...
2.
Shrine N, Guyatt A, Erzurumluoglu A, Jackson V, Hobbs B, Melbourne C, et al.
Nat Genet
. 2024 Apr;
56(5):1032-1033.
PMID: 38641645
No abstract available.
3.
Packer R, Shrine N, Hall R, Melbourne C, Thompson R, Williams A, et al.
Eur Respir J
. 2023 Jun;
61(6).
PMID: 37263751
Background: Chronic sputum production impacts on quality of life and is a feature of many respiratory diseases. Identification of the genetic variants associated with chronic sputum production in a disease...
4.
Allen R, Oldham J, Jenkins D, Leavy O, Guillen-Guio B, Melbourne C, et al.
Lancet Respir Med
. 2022 Aug;
11(1):65-73.
PMID: 35985358
Background: Idiopathic pulmonary fibrosis (IPF) is an incurable lung disease characterised by progressive scarring leading to alveolar stiffness, reduced lung capacity, and impeded gas transfer. We aimed to identify genetic...
5.
Melbourne C, Erzurumluoglu A, Shrine N, Chen J, Tobin M, Hansell A, et al.
Environ Int
. 2021 Dec;
159:107041.
PMID: 34923368
Background: Impaired lung function is predictive of mortality and is a key component of chronic obstructive pulmonary disease. Lung function has a strong genetic component but is also affected by...
6.
Kim W, Prokopenko D, Sakornsakolpat P, Hobbs B, Lutz S, Hokanson J, et al.
Am J Epidemiol
. 2020 Oct;
190(5):875-885.
PMID: 33106845
Risk of chronic obstructive pulmonary disease (COPD) is determined by both cigarette smoking and genetic susceptibility, but little is known about gene-by-smoking interactions. We performed a genome-wide association analysis of...
7.
John C, Reeve N, Free R, Williams A, Ntalla I, Farmaki A, et al.
Int J Epidemiol
. 2019 Aug;
48(5):1734.
PMID: 31365084
No abstract available.
8.
Shrine N, Guyatt A, Erzurumluoglu A, Jackson V, Hobbs B, Melbourne C, et al.
Nat Genet
. 2019 May;
51(6):1067.
PMID: 31110354
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
9.
John C, Reeve N, Free R, Williams A, Ntalla I, Farmaki A, et al.
Int J Epidemiol
. 2019 May;
48(3):678-679j.
PMID: 31062032
No abstract available.
10.
Shrine N, Guyatt A, Erzurumluoglu A, Jackson V, Hobbs B, Melbourne C, et al.
Nat Genet
. 2019 Feb;
51(3):481-493.
PMID: 30804560
Reduced lung function predicts mortality and is key to the diagnosis of chronic obstructive pulmonary disease (COPD). In a genome-wide association study in 400,102 individuals of European ancestry, we define...